Downstream tests, treatments, and annual direct payments in older men cared for by primary care providers with high or low prostate-specific antigen screening rates using 100 percent Texas U.S. Medicare public insurance claims data: a retrospective cohort study

BMC Health Services Research
Preeti ZanwarJames S Goodwin

Abstract

All authorities recommend against prostate specific antigen (PSA) screening in men 75 years and older. However, some primary care physicians (PCPs) continue to have high rates of PSA, with large variation in testing. We assessed the tests, treatments, and payments for prostate cancer care in men aged 75 or older who have PCPs with high or low PSA testing rates. We performed a retrospective cohort study using the 2010 Medicare beneficiaries aged 75 or older in Texas, United States who had no prostate cancer in 2007-2009 and had an identifiable PCP. We first identified high vs. low PSA testing PCPs, and then grouped older men in the two PCP groups. We determined health care visits to any provider and to urologists in office and outpatient settings. We estimated the direct medical payments for prostate cancer care for diagnostics, treatments and visits to providers in 2010-2011 using the generalized gamma model with log link function. In multilevel, multivariable analyses, 25.4% (n = 550) of PCPs had PSA testing rates in men aged 75 or older that were significantly higher than the mean rate of all 2,169 Texas PCPs; 29.4% (n = 638) had rates that were significantly lower. In all, 22,853 vs. 23,929 older men were cared for by PCPs w...Continue Reading

References

Feb 7, 1998·Medical Care·A ElixhauserR M Coffey
Jan 8, 2004·JAMA : the Journal of the American Medical Association·Lisa M SchwartzH Gilbert Welch
Apr 7, 2005·Journal of Health Economics·Willard G ManningJohn Mullahy
Nov 16, 2006·JAMA : the Journal of the American Medical Association·Louise C WalterBadrinath R Konety
Jul 6, 2007·Health Services Research·Baiju R ShahGillian L Booth
Jun 19, 2009·Medical Care·Anirban Basu, Willard G Manning
Sep 2, 2009·Journal of the National Cancer Institute·H Gilbert Welch, Peter C Albertsen
Mar 30, 2010·Journal of the American Geriatrics Society·Julie BynumElliott Fisher
Apr 20, 2010·Journal of the American Geriatrics Society·Jeff Whittle, Clement J Zablocki
Apr 21, 2011·BMC Health Services Research·Robert M Kaplan, Yair M Babad
Jun 29, 2011·Prostate Cancer and Prostatic Diseases·Y-H ShaoG L Lu-Yao
Apr 21, 2012·Cancer·Craig E PollackH Ballentine Carter
Jul 18, 2012·Annals of Internal Medicine·Virginia A Moyer, UNKNOWN U.S. Preventive Services Task Force
Dec 19, 2012·The Journal of Urology·Kirsten L GreeneUNKNOWN American Urological Association
Apr 17, 2013·JAMA Internal Medicine·Louise C WalterRichard M Hoffman
Jul 31, 2013·JAMA : the Journal of the American Medical Association·Laura J EssermanBrian Reid
Oct 17, 2013·JAMA : the Journal of the American Medical Association·Elizabeth JaramilloJames S Goodwin
Jun 7, 2014·International Journal of Cancer. Journal International Du Cancer·Peter HjertholmPeter Vedsted
Aug 5, 2014·JAMA : the Journal of the American Medical Association·Ian M ThompsonDonna P Ankerst

❮ Previous
Next ❯

Citations

Apr 21, 2017·Current Opinion in Urology·Jathin BandariBruce L Jacobs
Aug 29, 2020·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Staffan HäggJohan Ahlner
May 28, 2021·Cancer·Trevor C HuntBrock B O'Neil

❮ Previous
Next ❯

Methods Mentioned

BETA
biopsies
biopsy

Software Mentioned

SAS
MEDPAR

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.